ALDH2 and neoplasm: Both nanocomplexes demonstrated selective elevation of ROS (≥5 folds) and lipid peroxidation (≥2.5 folds) with lowering GSH level (>1.3 fold) and inhibiting ALDH2 activity (>36%) in tumor tissues (liver and lung).